Global Receptor Tyrosine Protein Kinase ERBB 3 Market Research Report 2021

Publisher Name :
Date: 11-Jan-2021
No. of pages: 115
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- BA-0702

- CDX-3379

- Elgemtumab

- ETBX-031

- Others

Segment by Application

- Non-Small Cell Carcinoma

- Solid Tumor

- Melanoma

- Colorectal Cancer

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- AstraZeneca Plc

- AVEO Pharmaceuticals, Inc.

- Etubics Corporation

- F. Hoffmann-La Roche Ltd.

- GamaMabs Pharma S.A.

- GlaxoSmithKline Plc

- Hanmi Pharmaceuticals, Co. Ltd.

- ImmunoGen, Inc.

- Kolltan Pharmaceuticals, Inc.

- Merrimack Pharmaceuticals, Inc.

- Merus B.V.

- Novartis AG

- Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

- Sihuan Pharmaceutical Holdings Group Ltd.

- Sorrento Therapeutics, Inc.

- Symphogen A/S

- Takis S.r.l.

Global Receptor Tyrosine Protein Kinase ERBB 3 Market Research Report 2021

Table of Contents
1 Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase ERBB 3
1.2 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Type
1.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 BA-0702
1.2.3 CDX-3379
1.2.4 Elgemtumab
1.2.5 ETBX-031
1.2.6 Others
1.3 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Application
1.3.1 Receptor Tyrosine Protein Kinase ERBB 3 Sales Comparison by Application: (2021-2027)
1.3.2 Non-Small Cell Carcinoma
1.3.3 Solid Tumor
1.3.4 Melanoma
1.3.5 Colorectal Cancer
1.3.6 Others
1.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Estimates and Forecasts
1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue 2016-2027
1.4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales 2016-2027
1.4.3 Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Region: 2016 Versus 2021 Versus 2027
2 Receptor Tyrosine Protein Kinase ERBB 3 Market Competition by Manufacturers
2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Manufacturers (2016-2021)
2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Sites, Area Served, Product Type
2.5 Receptor Tyrosine Protein Kinase ERBB 3 Market Competitive Situation and Trends
2.5.1 Receptor Tyrosine Protein Kinase ERBB 3 Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Receptor Tyrosine Protein Kinase ERBB 3 Players Market Share by Revenue
2.5.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Receptor Tyrosine Protein Kinase ERBB 3 Retrospective Market Scenario by Region
3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
3.3.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
3.3.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
3.4.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
3.4.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Region
3.5.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region
3.5.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
3.6.1 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
3.6.2 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
3.7.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
3.7.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Analysis by Type
4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2016-2021)
4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2016-2021)
4.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Type (2016-2021)
5 Global Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Analysis by Application
5.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2016-2021)
5.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2016-2021)
5.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AstraZeneca Plc
6.1.1 AstraZeneca Plc Corporation Information
6.1.2 AstraZeneca Plc Description and Business Overview
6.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca Plc Product Portfolio
6.1.5 AstraZeneca Plc Recent Developments/Updates
6.2 AVEO Pharmaceuticals, Inc.
6.2.1 AVEO Pharmaceuticals, Inc. Corporation Information
6.2.2 AVEO Pharmaceuticals, Inc. Description and Business Overview
6.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.2.4 AVEO Pharmaceuticals, Inc. Product Portfolio
6.2.5 AVEO Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Etubics Corporation
6.3.1 Etubics Corporation Corporation Information
6.3.2 Etubics Corporation Description and Business Overview
6.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Etubics Corporation Product Portfolio
6.3.5 Etubics Corporation Recent Developments/Updates
6.4 F. Hoffmann-La Roche Ltd.
6.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.4.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.4.4 F. Hoffmann-La Roche Ltd. Product Portfolio
6.4.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.5 GamaMabs Pharma S.A.
6.5.1 GamaMabs Pharma S.A. Corporation Information
6.5.2 GamaMabs Pharma S.A. Description and Business Overview
6.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.5.4 GamaMabs Pharma S.A. Product Portfolio
6.5.5 GamaMabs Pharma S.A. Recent Developments/Updates
6.6 GlaxoSmithKline Plc
6.6.1 GlaxoSmithKline Plc Corporation Information
6.6.2 GlaxoSmithKline Plc Description and Business Overview
6.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.6.4 GlaxoSmithKline Plc Product Portfolio
6.6.5 GlaxoSmithKline Plc Recent Developments/Updates
6.7 Hanmi Pharmaceuticals, Co. Ltd.
6.6.1 Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
6.6.2 Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
6.6.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hanmi Pharmaceuticals, Co. Ltd. Product Portfolio
6.7.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments/Updates
6.8 ImmunoGen, Inc.
6.8.1 ImmunoGen, Inc. Corporation Information
6.8.2 ImmunoGen, Inc. Description and Business Overview
6.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.8.4 ImmunoGen, Inc. Product Portfolio
6.8.5 ImmunoGen, Inc. Recent Developments/Updates
6.9 Kolltan Pharmaceuticals, Inc.
6.9.1 Kolltan Pharmaceuticals, Inc. Corporation Information
6.9.2 Kolltan Pharmaceuticals, Inc. Description and Business Overview
6.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Kolltan Pharmaceuticals, Inc. Product Portfolio
6.9.5 Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
6.10 Merrimack Pharmaceuticals, Inc.
6.10.1 Merrimack Pharmaceuticals, Inc. Corporation Information
6.10.2 Merrimack Pharmaceuticals, Inc. Description and Business Overview
6.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Merrimack Pharmaceuticals, Inc. Product Portfolio
6.10.5 Merrimack Pharmaceuticals, Inc. Recent Developments/Updates
6.11 Merus B.V.
6.11.1 Merus B.V. Corporation Information
6.11.2 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.11.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Merus B.V. Product Portfolio
6.11.5 Merus B.V. Recent Developments/Updates
6.12 Novartis AG
6.12.1 Novartis AG Corporation Information
6.12.2 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.12.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Novartis AG Product Portfolio
6.12.5 Novartis AG Recent Developments/Updates
6.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
6.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
6.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Product Portfolio
6.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.14 Sihuan Pharmaceutical Holdings Group Ltd.
6.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
6.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Sihuan Pharmaceutical Holdings Group Ltd. Product Portfolio
6.14.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments/Updates
6.15 Sorrento Therapeutics, Inc.
6.15.1 Sorrento Therapeutics, Inc. Corporation Information
6.15.2 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.15.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Sorrento Therapeutics, Inc. Product Portfolio
6.15.5 Sorrento Therapeutics, Inc. Recent Developments/Updates
6.16 Symphogen A/S
6.16.1 Symphogen A/S Corporation Information
6.16.2 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.16.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Symphogen A/S Product Portfolio
6.16.5 Symphogen A/S Recent Developments/Updates
6.17 Takis S.r.l.
6.17.1 Takis S.r.l. Corporation Information
6.17.2 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.17.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Takis S.r.l. Product Portfolio
6.17.5 Takis S.r.l. Recent Developments/Updates
7 Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Cost Analysis
7.1 Receptor Tyrosine Protein Kinase ERBB 3 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 3
7.4 Receptor Tyrosine Protein Kinase ERBB 3 Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors List
8.3 Receptor Tyrosine Protein Kinase ERBB 3 Customers
9 Receptor Tyrosine Protein Kinase ERBB 3 Market Dynamics
9.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry Trends
9.2 Receptor Tyrosine Protein Kinase ERBB 3 Growth Drivers
9.3 Receptor Tyrosine Protein Kinase ERBB 3 Market Challenges
9.4 Receptor Tyrosine Protein Kinase ERBB 3 Market Restraints
10 Global Market Forecast
10.1 Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Receptor Tyrosine Protein Kinase ERBB 3 by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase ERBB 3 by Type (2022-2027)
10.2 Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Receptor Tyrosine Protein Kinase ERBB 3 by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase ERBB 3 by Application (2022-2027)
10.3 Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Receptor Tyrosine Protein Kinase ERBB 3 by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase ERBB 3 by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Covered in This Study
Table 5. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Manufacturers (2016-2021)
Table 7. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Receptor Tyrosine Protein Kinase ERBB 3 Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Sites and Area Served
Table 11. Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
Table 12. Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Receptor Tyrosine Protein Kinase ERBB 3 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 3 as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2016-2021)
Table 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2016-2021)
Table 20. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2016-2021)
Table 22. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2016-2021)
Table 24. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2016-2021)
Table 30. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2016-2021)
Table 32. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2016-2021)
Table 38. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2016-2021)
Table 39. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2016-2021)
Table 40. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) by Type (2016-2021)
Table 41. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Type (2016-2021)
Table 42. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2016-2021)
Table 44. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2016-2021)
Table 45. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) by Application (2016-2021)
Table 46. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Application (2016-2021)
Table 47. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs) by Application (2016-2021)
Table 48. AstraZeneca Plc Corporation Information
Table 49. AstraZeneca Plc Description and Business Overview
Table 50. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 52. AstraZeneca Plc Recent Developments/Updates
Table 53. AVEO Pharmaceuticals, Inc. Corporation Information
Table 54. AVEO Pharmaceuticals, Inc. Description and Business Overview
Table 55. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 57. AVEO Pharmaceuticals, Inc. Recent Developments/Updates
Table 58. Etubics Corporation Corporation Information
Table 59. Etubics Corporation Description and Business Overview
Table 60. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 62. Etubics Corporation Recent Developments/Updates
Table 63. F. Hoffmann-La Roche Ltd. Corporation Information
Table 64. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 65. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 67. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 68. GamaMabs Pharma S.A. Corporation Information
Table 69. GamaMabs Pharma S.A. Description and Business Overview
Table 70. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 72. GamaMabs Pharma S.A. Recent Developments/Updates
Table 73. GlaxoSmithKline Plc Corporation Information
Table 74. GlaxoSmithKline Plc Description and Business Overview
Table 75. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 77. GlaxoSmithKline Plc Recent Developments/Updates
Table 78. Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
Table 79. Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
Table 80. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 82. Hanmi Pharmaceuticals, Co. Ltd. Recent Developments/Updates
Table 83. ImmunoGen, Inc. Corporation Information
Table 84. ImmunoGen, Inc. Description and Business Overview
Table 85. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 87. ImmunoGen, Inc. Recent Developments/Updates
Table 88. Kolltan Pharmaceuticals, Inc. Corporation Information
Table 89. Kolltan Pharmaceuticals, Inc. Description and Business Overview
Table 90. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 92. Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
Table 93. Merrimack Pharmaceuticals, Inc. Corporation Information
Table 94. Merrimack Pharmaceuticals, Inc. Description and Business Overview
Table 95. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 97. Merrimack Pharmaceuticals, Inc. Recent Developments/Updates
Table 98. Merus B.V. Corporation Information
Table 99. Merus B.V. Description and Business Overview
Table 100. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 102. Merus B.V. Recent Developments/Updates
Table 103. Novartis AG Corporation Information
Table 104. Novartis AG Description and Business Overview
Table 105. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 107. Novartis AG Recent Developments/Updates
Table 108. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 109. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 110. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 112. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 113. Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
Table 114. Sihuan Pharmaceutical Holdings Group Ltd. Description and Business Overview
Table 115. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 117. Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments/Updates
Table 118. Sorrento Therapeutics, Inc. Corporation Information
Table 119. Sorrento Therapeutics, Inc. Description and Business Overview
Table 120. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 122. Sorrento Therapeutics, Inc. Recent Developments/Updates
Table 123. Symphogen A/S Corporation Information
Table 124. Symphogen A/S Description and Business Overview
Table 125. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 127. Symphogen A/S Recent Developments/Updates
Table 128. Takis S.r.l. Corporation Information
Table 129. Takis S.r.l. Description and Business Overview
Table 130. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 131. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 132. Takis S.r.l. Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Receptor Tyrosine Protein Kinase ERBB 3 Distributors List
Table 136. Receptor Tyrosine Protein Kinase ERBB 3 Customers List
Table 137. Receptor Tyrosine Protein Kinase ERBB 3 Market Trends
Table 138. Receptor Tyrosine Protein Kinase ERBB 3 Growth Drivers
Table 139. Receptor Tyrosine Protein Kinase ERBB 3 Market Restraints
Table 140. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Type (2022-2027) & (K Pcs)
Table 141. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Type (2022-2027)
Table 142. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 143. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share Forecast by Type (2022-2027)
Table 144. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Application (2022-2027) & (K Pcs)
Table 145. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Application (2022-2027)
Table 146. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 147. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share Forecast by Application (2022-2027)
Table 148. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Region (2022-2027) & (K Pcs)
Table 149. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Region (2022-2027)
Table 150. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 151. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share Forecast by Region (2022-2027)
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Receptor Tyrosine Protein Kinase ERBB 3
Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type in 2020 & 2027
Figure 3. BA-0702 Product Picture
Figure 4. CDX-3379 Product Picture
Figure 5. Elgemtumab Product Picture
Figure 6. ETBX-031 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Application in 2020 & 2027
Figure 9. Non-Small Cell Carcinoma
Figure 10. Solid Tumor
Figure 11. Melanoma
Figure 12. Colorectal Cancer
Figure 13. Others
Figure 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2016-2027 (US$ Million)
Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales 2016-2027 (K Pcs)
Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Manufacturers in 2020
Figure 19. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Receptor Tyrosine Protein Kinase ERBB 3 Players: Market Share by Revenue in 2020
Figure 21. Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2016-2021)
Figure 23. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region in 2020
Figure 24. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2016-2021)
Figure 25. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region in 2020
Figure 26. U.S. Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Receptor Tyrosine Protein Kin
  • Global Bone Putty Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Orthopedic Surgery - Dental Surgery Segment by Application - Hospitals - Ambulatory S......
  • Global Chronic Pain Treatment Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 120
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Drugs - Devices Segment by Application - Hospitals - Clinics - Nursing Homes......
  • Global Prothrombin Complex Concentrates Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 92
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 3F Prothrombin Complex Concentrates - 4F Prothrombin Complex Concentrates Segment by Application......
  • Global Urology Drugs Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - ? (alpha) Blockers - 5 ?-reductase Inhibitors Segment by Application - Hospital - Cli......
  • Global Metoprolol Succinate Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 25mg - 50mg - 100mg - 200mg Segment by Application - Hypertension - Ang......
  • Global Prefilled Formalin Vials Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Below 10 mL - 10 - 20 mL - 20 - 40 mL - 40 - 60 mL - 60 - 90 mL - 90 - 500 mL -......
  • Global Sustained Release Excipients Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Gelatin - Polymers - Minerals - Sugars - Alcohol - Chitosan Segment by ......
  • Global Dermal Filler and Botolinum Toxin Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Hyaluronic Acid Based Fillers - Non-Hyaluronic Acid Based Fillers - Botulinum Toxin Segment ......
  • Global Branded Generics Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oral - Parenteral - Topical - Other Segment by Application - Oncology -......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs